project id: TCGA-LUAD; case submitter id: TCGA-05-4425; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; spectrophotometer method: UV Spec; age at index: 70; days to birth: -25902; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1938; age at diagnosis: 25902; ajcc pathologic m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 669.0; icd 10 code: C34.2; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle lobe, lung; synchronous malignancy: No; tissue or organ of origin: Middle lobe, lung; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 1.5342465753424657; pack years smoked: 28.0; is ffpe: false; portion number: 01; weight: 131.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.1; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-05-4425-01A-01; percent monocyte infiltration: 1.0; percent normal cells: 0.0;